Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Iovance Biotherapeutics (IOVA) Inventory Average (2023 - 2025)

Iovance Biotherapeutics (IOVA) has disclosed Inventory Average for 3 consecutive years, with $51.7 million as the latest value for Q4 2025.

  • On a quarterly basis, Inventory Average changed N/A to $51.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $51.7 million, a N/A change, with the full-year FY2025 number at $51.6 million, up 66.74% from a year prior.
  • Inventory Average was $51.7 million for Q4 2025 at Iovance Biotherapeutics, up from $50.8 million in the prior quarter.
  • In the past five years, Inventory Average ranged from a high of $58.5 million in Q1 2025 to a low of $9.5 million in Q3 2023.
  • A 3-year average of $36.0 million and a median of $50.8 million in 2025 define the central range for Inventory Average.
  • Biggest YoY gain for Inventory Average was 318.25% in 2025; the steepest drop was 318.25% in 2025.
  • Iovance Biotherapeutics' Inventory Average stood at $9.8 million in 2023, then soared by 43.04% to $14.0 million in 2024, then soared by 269.39% to $51.7 million in 2025.
  • Per Business Quant, the three most recent readings for IOVA's Inventory Average are $51.7 million (Q4 2025), $50.8 million (Q3 2025), and $57.7 million (Q2 2025).